We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ARAB HEALTH - INFORMA

Download Mobile App




Ban of CFC in Inhalers Spurs Product Innovation

By HospiMedica International staff writers
Posted on 06 Oct 2008
Print article
The respiratory disposables and reusable respiratory accessories market is undergoing a dramatic change caused in part by a recent U.S. government regulation that bans the use of chlorofluorocarbon (CFC) in inhalers.

A new report by Kalorama Information (New York, NY, USA) has found that more than 95% of inhalers used today contain ozone-depleting CFC as a propellant. To abide by international environmental guidelines, the United States released a new policy in 2005 that decreed that CFCs must be removed from inhalers by December 31, 2008, and be replaced with hydrofluoroalkane (HFA). As a result, inhaler equipment suppliers and pharmaceutical companies have been collaborating to face the phase-out, and are undertaking compound stability and product compatibility tests as a requirement for approval by the U.S. Food and Drug Administration (FDA). These new non-CFC inhalers will not see generic competition until they come off patent starting in 2010, and are therefore predicted to cost about twice as much as CFC inhalers. As a result, inhalers, which make up the lion's share of the U.S. US$36 billion market for respiratory devices, are expected to enjoy a strong 9.8% annual growth rate through 2012, spurred in part by new product innovations following the CFC ban.

"Compliance could be a blessing in disguise for inhaler companies,” said research analyst Joe Constance of Kalorama Information. "Until December 2007, companies with CFC-based products were allowed to market their product, so they have had sufficient time to take the necessary steps to shift towards HFA based products. And the companies did not need to make any significant changes in their manufacturing processes in order to abide by this new government regulation.”

HFA inhalers are designed to give the same dose of albuterol as current CFC inhalers. However, since HFAs are a different type of propellant, the albuterol HFA inhalers may taste and feel different. The force of the spray may feel softer from albuterol HFA than from albuterol CFC inhalers, and often hits the back of the mouth as a fine mist. Importantly, albuterol HFA inhalers have to be cleaned, dried, and primed to supply the right dose of medicine.

Related Links:
Kalorama Information

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
12-Channel ECG
CM1200B
New
Phototherapy Eye Protector
EyeMax2
New
Digital Radiographic System
OMNERA 300M

Print article

Channels

Surgical Techniques

view channel
Image: The new treatment combination for subdural hematoma reduces the risk of recurrence (Photo courtesy of Neurosurgery 85(6):801-807, December 2019)

Novel Combination of Surgery and Embolization for Subdural Hematoma Reduces Risk of Recurrence

Subdural hematomas, which occur when bleeding happens between the brain and its protective membrane due to trauma, are common in older adults. By 2030, chronic subdural hematomas are expected to become... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The acoustic pipette uses sound waves to test for biomarkers in blood (Photo courtesy of Patrick Campbell/CU Boulder)

Handheld, Sound-Based Diagnostic System Delivers Bedside Blood Test Results in An Hour

Patients who go to a doctor for a blood test often have to contend with a needle and syringe, followed by a long wait—sometimes hours or even days—for lab results. Scientists have been working hard to... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.